Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/65384
Type
ArticleCopyright
Open access
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
Metadata
Show full item record
COMPREHENSIVE ANALYSIS OF EARLY T CELL RESPONSES TO ACUTE ZIKA VIRUS INFECTION DURING THE FIRST EPIDEMIC IN BAHIA, BRAZIL
Author
Samri, Assia
Bandeira, Antonio Carlos
Gois, Luana Leandro
Silva, Carlos Gustavo Regis
Rousseau, Alice
Corneau, Aurelien
Tarantino, Nadine
Maucourant, Christopher
Queiroz, Gabriel Andrade Nonato
Vieillard, Vincent
Yssel, Hans
Campos, Gubio Soares
Sardi, Silvia
Autran, Brigitte
Grassi, Maria Fernanda Rios
Bandeira, Antonio Carlos
Gois, Luana Leandro
Silva, Carlos Gustavo Regis
Rousseau, Alice
Corneau, Aurelien
Tarantino, Nadine
Maucourant, Christopher
Queiroz, Gabriel Andrade Nonato
Vieillard, Vincent
Yssel, Hans
Campos, Gubio Soares
Sardi, Silvia
Autran, Brigitte
Grassi, Maria Fernanda Rios
Affilliation
Sorbonne-Université. Inserm 1135. CNRS ERL8255. Centre d’Immunologie et des Maladies Infectieuses.Cimi, Paris, France.
Secretaria de Saúde da Bahia. Salvador, BA, Brasil / Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil.
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Escola Bahiana de Medicina e Saúde Pública. Salvador, Brasil / Universidade Federal da Bahia. Instituto de Ciências da Saúde. Departamento de Biointeracão. Salvador, BA, Brasil.
Escola Bahiana de Medicina e Saúde Pública. Salvador, Brasil.
Sorbonne-Université. Inserm 1135. CNRS ERL8255. Centre d’Immunologie et des Maladies Infectieuses.Cimi, Paris, France
Faculté de Medicine Pierre et Marie Curie. Plateforme de Cytomé trie. UMS30–LUMIC. Paris, France.
Sorbonne-Université. Inserm 1135. CNRS ERL8255. Centre d’Immunologie et des Maladies Infectieuses.Cimi, Paris, France.
Sorbonne-Université. Inserm 1135. CNRS ERL8255. Centre d’Immunologie et des Maladies Infectieuses.Cimi, Paris, France.
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Escola Bahiana de Medicina e Saúde Pública. Salvador, Brasil.
Sorbonne-Université. Inserm 1135. CNRS ERL8255. Centre d’Immunologie et des Maladies Infectieuses.Cimi, Paris, France.
Sorbonne-Université. Inserm 1135. CNRS ERL8255. Centre d’Immunologie et des Maladies Infectieuses.Cimi, Paris, France.
Universidade Federal da Bahia. Instituto de Ciências da Saúde. Departamento de Biointeracão. Salvador, BA, Brasil.
Universidade Federal da Bahia. Instituto de Ciências da Saúde. Departamento de Biointeracão. Salvador, BA, Brasil.
Sorbonne-Université. Inserm 1135. CNRS ERL8255. Centre d’Immunologie et des Maladies Infectieuses.Cimi, Paris, France.
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Escola Bahiana de Medicina e Saúde Pública. Salvador, Brasil.
Secretaria de Saúde da Bahia. Salvador, BA, Brasil / Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil.
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Escola Bahiana de Medicina e Saúde Pública. Salvador, Brasil / Universidade Federal da Bahia. Instituto de Ciências da Saúde. Departamento de Biointeracão. Salvador, BA, Brasil.
Escola Bahiana de Medicina e Saúde Pública. Salvador, Brasil.
Sorbonne-Université. Inserm 1135. CNRS ERL8255. Centre d’Immunologie et des Maladies Infectieuses.Cimi, Paris, France
Faculté de Medicine Pierre et Marie Curie. Plateforme de Cytomé trie. UMS30–LUMIC. Paris, France.
Sorbonne-Université. Inserm 1135. CNRS ERL8255. Centre d’Immunologie et des Maladies Infectieuses.Cimi, Paris, France.
Sorbonne-Université. Inserm 1135. CNRS ERL8255. Centre d’Immunologie et des Maladies Infectieuses.Cimi, Paris, France.
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Escola Bahiana de Medicina e Saúde Pública. Salvador, Brasil.
Sorbonne-Université. Inserm 1135. CNRS ERL8255. Centre d’Immunologie et des Maladies Infectieuses.Cimi, Paris, France.
Sorbonne-Université. Inserm 1135. CNRS ERL8255. Centre d’Immunologie et des Maladies Infectieuses.Cimi, Paris, France.
Universidade Federal da Bahia. Instituto de Ciências da Saúde. Departamento de Biointeracão. Salvador, BA, Brasil.
Universidade Federal da Bahia. Instituto de Ciências da Saúde. Departamento de Biointeracão. Salvador, BA, Brasil.
Sorbonne-Université. Inserm 1135. CNRS ERL8255. Centre d’Immunologie et des Maladies Infectieuses.Cimi, Paris, France.
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Escola Bahiana de Medicina e Saúde Pública. Salvador, Brasil.
Abstract
Background: In most cases, Zika virus (ZIKV) causes a self-limited acute illness in adults, characterized by mild clinical symptoms that resolve within a few days. Immune responses, both innate and adaptive, play a central role in controlling and eliminating virus-infected cells during the early stages of infection. Aim: To test the hypothesis that circulating T cells exhibit phenotypic and functional activation characteristics during the viremic phase of ZIKV infection. Methods: A comprehensive analysis using mass cytometry was performed on peripheral blood mononuclear cells obtained from patients with acute ZIKV infection (as confirmed by RT-PCR) and compared with that from healthy donors (HD). The frequency of IFN-γ-producing T cells in response to peptide pools covering immunogenic regions of structural and nonstructural ZIKV proteins was quantified using an ELISpot assay. Results: Circulating CD4+ and CD8+ T lymphocytes from ZIKV-infected patients expressed higher levels of IFN-γ and pSTAT-5, as well as cell surface markers associated with proliferation (Ki-67), activation ((HLA-DR, CD38) or exhaustion (PD1 and CTLA-4), compared to those from HD. Activation of CD4+ and CD8+ memory T cell subsets, including Transitional Memory T Cells (TTM), Effector Memory T cells (TEM), and Effector Memory T cells Re-expressing CD45RA (TEMRA), was prominent among CD4+ T cell subset of ZIKV-infected patients and was associated with increased levels of IFN-γ, pSTAT-5, Ki-67, CTLA-4, and PD1, as compared to HD. Additionally, approximately 30% of ZIKV-infected patients exhibited a T cell response primarily directed against the ZIKV NS5 protein. Conclusion: Circulating T lymphocytes spontaneously produce IFN-γ and express elevated levels of pSTAT-5 during the early phase of ZIKV infection whereas recognition of ZIKV antigen results in the generation of virus-specific IFN-γ-producing T cells.
Share